Sewer sampling, the authors say, could be expanded to track other infectious diseases such as H5N1 avian flu or mpox or to detect unexpected pathogens.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
About 75% of COVID-19 deaths in the least-vaccinated Chicago areas could have been prevented if their uptake would have equaled that of the highest-coverage areas during the Alpha and Delta variant surges, suggests a study late last week in JAMA Network Open.
Long COVID can affect even fully vaccinated people after mild breakthrough infections.
International survey finds 62% reported 1 or more symptoms of burnout, and 31% reported 2.
Symptomatic COVID-19 cases are responsible for more viral transmission than asymptomatic infections, suggests an updated systematic review and meta-analysis of 130 studies published yesterday in PLOS Medicine.
Weekly prescriptions for oral COVID-19 antivirals rose from about 27,000 to more than 182,000 in 7 weeks.
A letter yesterday in the New England Journal of Medicine (NEJM) from Centers for Disease Control and Prevention scientists shows homologous (same-vaccine) boosting for Johnson & Johnson (J&J) vaccine recipients was significantly less effective than mix-and-match booster doses when the Omicron strain was predominant in the United States.
Two global regions that saw recent increases in infections are now seeing downturns, but the US reports the most new cases and deaths.
Transmission of COVID-19 was significantly lower, and viable virus was detected for a shorter period, in fully vaccinated patients and staff isolated at a South Korean hospital than in their partially vaccinated and unvaccinated counterparts, finds a study published yesterday in JAMA Network Open.
The agency also alerts clinicians about COVID-19 rebound after Paxlovid.
COVID-19 patients had persistent signs of heart and lung involvement, inflammation, and clotting.
